معرفی
Dennis Alferez-Castro, PhD, is a research scientist at the University of Manchester's Faculty of Biology, Medicine and Health, affiliated with the Department of Surgery and Cancer, Cancer Manchester, and the Christabel Pankhurst Institute. His work focuses on breast cancer metastasis, cancer stem cells, and xenograft modeling within the Precision Medicine Institute framework.
His research expertise spans oncology, cancer stem cell biology, metastasis mechanisms, steroid hormone signaling, and patient-derived xenograft models. Key contributions involve elucidating IL1β/Wnt signaling in bone metastasis, STAT3 inhibition in endocrine resistance, and conservation of genomic profiles in PDX models. His work directly supports UN Sustainable Development Goals through cancer research innovation.
Analysis of his 15 most recent publications reveals dominant trends in bone metastasis microenvironment interactions (60%), cancer stem cell targeting (53%), and translational xenograft modeling (47%). His research bridges molecular mechanisms with clinical applications, particularly in endocrine-resistant breast cancer subtypes.
As an active consortium member, he contributes to the PDXNET and EurOPDX international collaborations standardizing patient-derived models. His work has been referenced in 6 Wikipedia pages, covered by 23 news outlets, and shared across 89 X (Twitter) platforms, indicating significant scientific impact.
He operates within the Cancer Manchester research ecosystem, utilizing advanced platforms including the Christabel Pankhurst Institute's women's health facilities and the Precision Medicine Institute's translational infrastructure. Current projects focus on metastatic niche characterization and therapeutic targeting of stem-like cell populations in treatment-resistant disease.
